Analysis

Pharma Technology Focus – Issue 63

Pharma Technology Focus – Issue 63

Mining fungi: a fountain of new medicines?

Mining fungi: a fountain of new medicines?

Osteoporosis breakthrough: positive news in a field plagued by bad press

Osteoporosis breakthrough: positive news in a field plagued by bad press

1 in 5: why the UK pharma industry is going to court over spending caps

1 in 5: why the UK pharma industry is going to court over spending caps

August's top stories: Mylan launched anti-retroviral treatments, Fosun updated on $1.3bn takeover

August's top stories: Mylan launched anti-retroviral treatments, Fosun updated on $1.3bn takeover

Is Amazon gearing up to take on the US pharmacy market?

Is Amazon gearing up to take on the US pharmacy market?

Pharma Technology Focus – Issue 62

Pharma Technology Focus – Issue 62

Zika virus: an unlikely new anti-cancer candidate

Zika virus: an unlikely new anti-cancer candidate

New library building the LINC between pharmaceutical industry and academia

New library building the LINC between pharmaceutical industry and academia

July's top stories: Researchers found epithelial cells prevent Ebola, Mitsubishi agreed to buy NeuroDerm

July's top stories: Researchers found epithelial cells prevent Ebola, Mitsubishi agreed to buy NeuroDerm

Closing the US pharmaceutical industry’s growing skills gap

Closing the US pharmaceutical industry’s growing skills gap

PhRMA: resetting the conversation

PhRMA: resetting the conversation

Do healthcare cuts risk creating a ‘desert for innovation’ in the UK?

Do healthcare cuts risk creating a ‘desert for innovation’ in the UK?

Betting big on Gamma Delta T Cells

Betting big on Gamma Delta T Cells

Pharma Technology Focus – Issue 61

Pharma Technology Focus – Issue 61

Cystic fibrosis: searching for a breakthrough

Cystic fibrosis: searching for a breakthrough

US drug imports: a recipe for disaster?

US drug imports: a recipe for disaster?

Treating mononucleosis: why the mystery?

Treating mononucleosis: why the mystery?

Reforming paediatric cancer trials in Europe

Reforming paediatric cancer trials in Europe

Immuno-oncology: where to go in a packed field

Immuno-oncology: where to go in a packed field

June's top stories: Takeda and Biological E. collaborated, J&J completed Actelion acquisition

June's top stories: Takeda and Biological E. collaborated, J&J completed Actelion acquisition